Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 24
DEFA14A
Additional proxy soliciting materials
28 May 24
8-K
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
28 May 24
8-K
Regulation FD Disclosure
15 May 24
S-8
Registration of securities for employees
13 May 24
10-Q
2024 Q1
Quarterly report
13 May 24
8-K
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
13 May 24
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
8-K
Regulation FD Disclosure
25 Mar 24
424B4
Prospectus supplement with pricing info
11 Mar 24
EFFECT
Notice of effectiveness
8 Mar 24
S-1MEF
Registration of additional securities for an S-1
7 Mar 24
S-1
IPO registration
5 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
10-K
2023 FY
Annual report
5 Mar 24
8-K
Apogee Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
5 Mar 24
DRS
Draft registration statement
9 Feb 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Apogee Highlights Corporate Progress and Reports Third Quarter 2023 Financial Results
13 Nov 23
S-8
Registration of securities for employees
28 Aug 23
10-Q
2023 Q2
Quarterly report
28 Aug 23
8-K
Apogee Highlights Corporate Progress and Reports Second Quarter 2023 Financial Results
28 Aug 23
8-K
Departure of Directors or Certain Officers
21 Aug 23
8-K
Regulation FD Disclosure
7 Aug 23
SEC STAFF
SEC staff action: Order
25 Jul 23
424B4
Prospectus supplement with pricing info
17 Jul 23
EFFECT
Notice of effectiveness
14 Jul 23
S-1MEF
Registration of additional securities for an S-1
13 Jul 23
CERT
Certification of approval for exchange listing
12 Jul 23
CORRESP
Correspondence with SEC
11 Jul 23
CORRESP
Correspondence with SEC
11 Jul 23
8-A12B
Registration of securities on exchange
10 Jul 23
S-1/A
IPO registration (amended)
10 Jul 23
CORRESP
Correspondence with SEC
10 Jul 23
S-1/A
IPO registration (amended)
3 Jul 23
UPLOAD
Letter from SEC
30 Jun 23
S-1
IPO registration
22 Jun 23
CORRESP
Correspondence with SEC
22 Jun 23
Latest ownership filings
4
WILLIAM A JONES JR
7 Jun 24
4
Mark C. McKenna
7 Jun 24
4
Lisa Bollinger
7 Jun 24
4
Jennifer A. Fox
7 Jun 24
4
Nimish P Shah
7 Jun 24
4
Andrew Gottesdiener
7 Jun 24
4
Peter Evan Harwin
7 Jun 24
4
Lisa Bollinger
30 May 24
3
Lisa Bollinger
30 May 24
4
Peter Evan Harwin
1 Apr 24
SC 13D/A
Fairmount Funds Management LLC
1 Apr 24
SC 13G
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
4
Peter Evan Harwin
31 Jan 24
SC 13D/A
Fairmount Funds Management LLC
31 Jan 24
4
Carl Dambkowski
20 Dec 23
4
Jane Henderson
20 Dec 23
4
MICHAEL THOMAS HENDERSON
20 Dec 23
SC 13G
ACCESS INDUSTRIES MANAGEMENT, LLC
3 Nov 23
4
Mark C. McKenna
21 Aug 23
3
Mark C. McKenna
21 Aug 23
SC 13G
FMR LLC
10 Aug 23
SC 13D
Venrock Healthcare Capital Partners III, L.P.
28 Jul 23
SC 13G
Deep Track Capital, LP
24 Jul 23
SC 13D
Fairmount Funds Management LLC
21 Jul 23
4
Andrew Gottesdiener
17 Jul 23
4
Nimish P Shah
17 Jul 23
4
Peter Evan Harwin
17 Jul 23
3/A
Carl Dambkowski
17 Jul 23
3/A
Jane Henderson
17 Jul 23
3/A
MICHAEL THOMAS HENDERSON
17 Jul 23
3/A
Jennifer A. Fox
17 Jul 23
3/A
WILLIAM A JONES JR
17 Jul 23
3
Carl Dambkowski
13 Jul 23
3
Jane Henderson
13 Jul 23
3
MICHAEL THOMAS HENDERSON
13 Jul 23
3
Jennifer A. Fox
13 Jul 23
3
WILLIAM A JONES JR
13 Jul 23
3
Andrew Gottesdiener
13 Jul 23